Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.
about
Spinal cord atrophy and disability in multiple sclerosis over four years.Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value.Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis.Imaging of multiple sclerosis: role in neurotherapeutics.High-resolution myelin water imaging in post-mortem multiple sclerosis spinal cord: A case report.Multiple sclerosis findings in the spinal cord.Imaging as an Outcome Measure in Multiple Sclerosis.Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis.Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis.In vivo imaging of spinal cord atrophy in neuroinflammatory diseases.The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis.Approaches to normalization of spinal cord volume: application to multiple sclerosisThe effect of intramuscular interferon beta-1a on spinal cord volume in relapsing-remitting multiple sclerosisIncreasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year studyAutomatic magnetic resonance spinal cord segmentation with topology constraints for variable fields of view.Diffusion tensor imaging detects treatment effects of FTY720 in experimental autoimmune encephalomyelitis mice.The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis.Spinal cord markers in ALS: diagnostic and biomarker considerations.Remyelinating strategies in multiple sclerosis.Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study.Secondary Progressive Multiple Sclerosis: Definition and Measurement.Association of asymptomatic spinal cord lesions and atrophy with disability 5 years after a clinically isolated syndrome.Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.Meningeal T cells associate with diffuse axonal loss in multiple sclerosis spinal cords.The Role of Advanced Magnetic Resonance Imaging Techniques in Multiple Sclerosis Clinical Trials.Putaminal alteration in multiple sclerosis patients with spinal cord lesions.MRI-Based Measurement of Brain Stem Cross-Sectional Area in Relapsing-Remitting Multiple Sclerosis.Application of Color Transformation Techniques in Pediatric Spinal Cord MR Images: Typically Developing and Spinal Cord Injury Population.Cervical spinal cord volume loss is related to clinical disability progression in multiple sclerosis.Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.Cervical spinal cord atrophy: An early marker of progressive MS onset.A longitudinal MRI study of cervical cord atrophy in multiple sclerosis.Comparison of three different methods for measurement of cervical cord atrophy in multiple sclerosis.Medulla Oblongata Volume: A Biomarker of Spinal Cord Damage and Disability in Multiple Sclerosis: Fig 1
P2860
Q30495470-5FE4022F-CD6C-4E90-A835-CFE8A34DB5FAQ30958322-C3E2DAF6-8B18-4319-97CF-7549835143ECQ30983016-F195D266-42B7-46A8-914A-FC18523A8ED7Q30989935-58AE7886-CE4B-4383-9550-9797CD596E23Q31040556-3F589096-EAC7-4C22-920C-4C303D675018Q31128783-318E6430-D26E-4213-BDE9-0484F71D872EQ31134617-4371DCF2-08B5-4D8F-A42B-17D57B094721Q33608445-39ABAAF4-232B-4466-8AC6-B07CA26AA18BQ33694036-C895D903-D35A-40FF-B283-9139FE5528D9Q34195686-C487E488-DFF6-4535-A431-024CDA21967EQ35082344-69895740-08F6-44AA-90B3-F68952C3BDE9Q35791298-6592BBFF-8A29-4079-9B24-FCF8A6797EE8Q36156669-C057448F-D75A-4376-94AE-004E725A833DQ36226297-54B76BE2-1D73-4B71-91FE-47F16C1C8741Q37296062-09DE5426-18E6-486B-8190-C7F25CEEF0EBQ37337129-89B11D99-0455-4C23-9308-382E4EA98A5EQ37596025-A12F7862-9078-4748-A4AF-36BAE9DBFEA3Q37983648-EECFF761-A51F-4246-B91E-4EE93CF4D52BQ38261543-1FB92548-F641-4E1E-B2B1-359237329817Q38672618-2EAA8A1A-4DE6-4DDB-9DE4-C850FCF04C8DQ38831720-4852E6CE-CD0E-4E69-B5A7-1488B0C9E873Q38923464-6AF7E87B-EB7B-48FA-8AEA-D2A9C5C648AAQ41686940-0635436D-6896-4C34-897F-1955DAC48EB0Q47237680-43A4FF64-77B2-4F96-8B62-F1B1337AB4CBQ48099284-F775E157-9B7B-4BB5-A8C5-539373202E5AQ48168382-3BF83E7F-1DD1-42B1-A819-9C0688C758B1Q48179442-B197E7E0-81D4-4FB0-8DBC-0C1D98D8C623Q48220840-AA5BEB01-0914-45B6-B84F-1644D04EECB6Q48515131-8809383A-1C72-4CB4-9383-8135039830EFQ48690785-1FA18B05-6D7D-426F-9A18-E9189A4D7F47Q48695171-751F1581-4466-4891-94A0-D2F588D98AF3Q49760918-975FBC6C-ECD7-4A51-98F2-A47ED8678664Q50922131-FDDCF3C3-7EAD-46FF-83D6-10CDA8BFE026Q53455681-FEE8D8AF-5CF6-4EA1-8CA4-78D03C0A9849Q57083586-155F2241-456A-424D-8487-91083594014B
P2860
Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Spinal cord atrophy and disabi ...... ta-1a (Rebif) treatment trial.
@ast
Spinal cord atrophy and disabi ...... ta-1a (Rebif) treatment trial.
@en
type
label
Spinal cord atrophy and disabi ...... ta-1a (Rebif) treatment trial.
@ast
Spinal cord atrophy and disabi ...... ta-1a (Rebif) treatment trial.
@en
prefLabel
Spinal cord atrophy and disabi ...... ta-1a (Rebif) treatment trial.
@ast
Spinal cord atrophy and disabi ...... ta-1a (Rebif) treatment trial.
@en
P2093
P2860
P921
P356
P1476
Spinal cord atrophy and disabi ...... ta-1a (Rebif) treatment trial.
@en
P2093
Blumhardt LD
Constantinescu CS
P2860
P304
P356
10.1136/JNNP.74.8.1090
P407
P577
2003-08-01T00:00:00Z